These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15254018)

  • 21. Structural Basis for the Enzymatic Activity of the HACE1 HECT-Type E3 Ligase Through N-Terminal Helix Dimerization.
    Singh S; Machida S; Tulsian NK; Choong YK; Ng J; Shankar S; Liu Y; Chandiramani KV; Shi J; Sivaraman J
    Adv Sci (Weinh); 2023 Sep; 10(27):e2207672. PubMed ID: 37537642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HACE1, a potential tumor suppressor gene on 6q21, is not involved in extranodal natural killer/T-cell lymphoma pathophysiology.
    Sako N; Dessirier V; Bagot M; Bensussan A; Schmitt C
    Am J Pathol; 2014 Nov; 184(11):2899-907. PubMed ID: 25203537
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WT1: a novel tumor suppressor gene inactivated in Wilms' tumor.
    Haber DA; Buckler AJ
    New Biol; 1992 Feb; 4(2):97-106. PubMed ID: 1313285
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Der(16)t(1;16)(q21;q13) in Wilms' tumor: friend or foe.
    Mathew P; Douglass EC; Jones D; Valentine M; Valentine V; Rowe S; Shapiro DN
    Med Pediatr Oncol; 1996 Jul; 27(1):3-7. PubMed ID: 8614388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of the 11p13 Wilms' tumor gene, WT1, correlates with histologic category of Wilms' tumor.
    Gerald WL; Gramling TS; Sens DA; Garvin AJ
    Am J Pathol; 1992 May; 140(5):1031-7. PubMed ID: 1316081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of region t(5;6)(q21;q21) in Wilms tumor.
    Bruce CK; Howard P; Nowak NJ; Hoban PR
    Cancer Genet Cytogenet; 2003 Mar; 141(2):106-13. PubMed ID: 12606127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-suppressive role of HACE1 in hepatocellular carcinoma and its clinical significance.
    Gao ZF; Wu YN; Bai ZT; Zhang L; Zhou Q; Li X
    Oncol Rep; 2016 Dec; 36(6):3427-3435. PubMed ID: 27805249
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genomic profiling maps loss of heterozygosity and defines the timing and stage dependence of epigenetic and genetic events in Wilms' tumors.
    Yuan E; Li CM; Yamashiro DJ; Kandel J; Thaker H; Murty VV; Tycko B
    Mol Cancer Res; 2005 Sep; 3(9):493-502. PubMed ID: 16179496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aberrant imprinting of the insulin-like growth factor II receptor gene in Wilms' tumor.
    Xu YQ; Grundy P; Polychronakos C
    Oncogene; 1997 Mar; 14(9):1041-6. PubMed ID: 9070652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nuclear accumulation of beta-catenin protein in Wilms' tumours.
    Koesters R; Niggli F; von Knebel Doeberitz M; Stallmach T
    J Pathol; 2003 Jan; 199(1):68-76. PubMed ID: 12474228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.
    Glaser T; Lewis WH; Bruns GA; Watkins PC; Rogler CE; Shows TB; Powers VE; Willard HF; Goguen JM; Simola KO
    Nature; 1986 Jun 26-Jul 2; 321(6073):882-7. PubMed ID: 3014343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isolation of kidney complementary DNAs down-expressed in Wilms' tumor by a subtractive hybridization approach.
    Austruy E; Cohen-Salmon M; Antignac C; Béroud C; Henry I; Nguyen VC; Brugières L; Junien C; Jeanpierre C
    Cancer Res; 1993 Jun; 53(12):2888-94. PubMed ID: 7916648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of E2F3 expression with clinicopathological features of Wilms' tumors.
    An Q; Wang Y; An R; Li Y; Yao T; Zhai B; Sun X
    J Pediatr Surg; 2013 Nov; 48(11):2187-93. PubMed ID: 24210184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor suppressor candidate TSSC5 is regulated by UbcH6 and a novel ubiquitin ligase RING105.
    Yamada HY; Gorbsky GJ
    Oncogene; 2006 Mar; 25(9):1330-9. PubMed ID: 16314844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p57K1P2 is expressed in Wilms' tumor with LOH of 11p15.5.
    Overall ML; Spencer J; Bakker M; Dziadek M; Smith PJ
    Genes Chromosomes Cancer; 1996 Sep; 17(1):56-9. PubMed ID: 8889507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Wilms' tumors and malformation complexes].
    Hata J; Fukuzawa R; Takata A; Kikuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.
    Liu JJ; Wang ZY; Deuel TF; Xu YH
    Biochem Biophys Res Commun; 1999 Jan; 254(1):197-9. PubMed ID: 9920757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-resolution molecular cytogenetic analysis of Wilms tumors highlights diagnostic difficulties among small round cell kidney tumors.
    Stewénius Y; Jin Y; Ora I; Panagopoulos I; Möller E; Mertens F; Sandstedt B; Alumets J; Akerman M; Merks JH; de Kraker J; Gisselsson D
    Genes Chromosomes Cancer; 2008 Oct; 47(10):845-52. PubMed ID: 18615675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNA polymerase chain reaction detects different levels of four alternatively spliced WT1 transcripts in Wilms' tumors.
    Brenner B; Wildhardt G; Schneider S; Royer-Pokora B
    Oncogene; 1992 Jul; 7(7):1431-3. PubMed ID: 1320246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular biology of Wilms' tumor.
    Koo HP; Hensle TW
    Urol Clin North Am; 1993 May; 20(2):323-31. PubMed ID: 8388135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.